ReproCELL Incorporated
4978.TJPXHealthcareBiotechnology
Latest quote
¥150
¥0.00 · 0.00%
4978.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteEstablished in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell applications, including a diverse array of specialized reagents for RNA reprogramming, cell growth (such as small molecules, growth factors, and cytokines), cell characterization (like antibodies and staining kits), cell culture (including pluripotent stem cell media and cell substrates), and cell handling (such as cryopreservation media, dissociation solutions, and transfection reagents). Furthermore, ReproCELL provides differentiated induced pluripotent stem cells (iPSCs), related components like feeder cells and induced neurons, 3D cell culture systems, and general laboratory consumables. Complementing its product lines, the company offers a comprehensive suite of services, spanning preclinical genomics, dedicated stem cell research, drug development support (encompassing efficacy, safety, and ADME analyses), access to human tissue samples, therapeutic pipeline development, and a range of clinical services, including laboratory diagnostics and the creation of GMP iPSC master cell banks.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Chikafumi Yokoyama
- Listed since
- Jun 26, 2013
- Employees
- 101
Market position
Day range
Current ¥150
52-week range
Current ¥150
- Open
- ¥151
- Previous close
- ¥150
- Volume
- 338.4K
- 0.59× average
- Average volume
- 576.51K
- Average daily volume
- Market cap
- 14.69B JPY
- Beta
- 0.53
- Market reference 1
- 50-day average
- ¥130.3
- +15.12% above average
- 200-day average
- ¥153.89
- -2.52% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 14.06B JPY
- P/E (TTM)
- -32.68×
- P/B (TTM)
- 1.58×
- P/S (TTM)
- 6.38×
- EV / EBITDA
- -17.91×
- Earnings yield
- -3.55%
- Free cash flow yield
- -2.89%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 46.14%
- Operating margin
- -38.19%
- Net margin
- -18.96%
- Return on equity
- -6.69%
- Return on assets
- -6.13%
- Return on invested capital
- -9.52%
Financial health
- Debt / equity
- 0×
- Current ratio
- 11.87×
- Altman Z-score
- 12.61
- Piotroski F-score
- 3 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.23B JPY | 2.98B JPY | 2.43B JPY | 2.95B JPY | 2.23B JPY |
| Cost of goods sold | 1.22B JPY | 1.35B JPY | 1.32B JPY | 1.83B JPY | 1.45B JPY |
| Gross profit | 1.01B JPY | 1.63B JPY | 1.1B JPY | 1.13B JPY | 785.42M JPY |
| Research and development | 627.17M JPY | 536.79M JPY | 384.95M JPY | 501.51M JPY | 535.29M JPY |
| Selling, general, and administrative | 1.25B JPY | 1.22B JPY | 1.13B JPY | 982.41M JPY | 897.26M JPY |
| Operating expenses | 1.87B JPY | 1.76B JPY | 1.51B JPY | 1.48B JPY | 1.43B JPY |
| Interest income | 87.8M JPY | 67.44M JPY | 51.19M JPY | 43.47M JPY | 9.18M JPY |
| Interest expense | — | — | — | 80K JPY | 342K JPY |
| Depreciation and amortization | 74.96M JPY | 50.71M JPY | 37.11M JPY | 48.99M JPY | 59.75M JPY |
| Operating income | −860.06M JPY | −130.41M JPY | −409.29M JPY | −356.22M JPY | −647.13M JPY |
| Net income | −591.69M JPY | 103.25M JPY | −31.42M JPY | −305.31M JPY | −575.1M JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 83%
- 5 beats, 1 miss, 0 met estimates
- Average EPS surprise
- +121.84%
- 6 comparable reports
- Latest EPS result
- -1.56
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 28, 2013 | 5:1 | — | — |
Effective Aug 28, 2013
5:1
4978.T peers
ETFs holding 4978.T
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR Portfolio Developed World ex-US ETFSPDW- Market value
- 762.94K
- Weight
- 0.00%
- AUM
- 41.92B USD
- Expense ratio
- 0.03%
- Price / 1D
- $52.02+0.79%
State Street SPDR S&P International Small Cap ETFGWX- Market value
- 49.04K
- Weight
- 0.01%
- AUM
- 927.26M USD
- Expense ratio
- 0.40%
- Price / 1D
- $46.205+0.40%
Dimensional World ex U.S. Core Equity 2 ETFDFAX- Market value
- 18.68K
- Weight
- 0.00%
- AUM
- 12.57B USD
- Expense ratio
- 0.28%
- Price / 1D
- $38.16+0.82%
Continue in GoAI
Research 4978.Tresearch.disclaimer